Entry |
|
Name |
Corticotropin zinc hydroxide; Corticotropin-Zinc (TN) |
Class |
Hormonal agent
DG01629 Adrenocorticotropic hormone (ACTH)
|
Remark |
Product (DG00492): | D00146<US> |
|
Efficacy |
Diagnostic (adrenocortical insufficiency), Melanocortin receptor 2 agonist |
Comment |
Glucocorticoid
Adrenocorticotropic hormone (ACTH)
|
Target |
|
Pathway |
hsa04080 | Neuroactive ligand-receptor interaction |
hsa04925 | Aldosterone synthesis and secretion |
hsa04927 | Cortisol synthesis and secretion |
|
Interaction |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
H01 PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES
H01A ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES
H01AA ACTH
H01AA01 Corticotropin
D03593 Corticotropin zinc hydroxide
Drug groups [BR:br08330]
Hormonal agent
DG01629 Adrenocorticotropic hormone (ACTH)
DG00492 Corticotropin
D03593 Corticotropin zinc hydroxide
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Melanocortin
MC2R
D03593 Corticotropin zinc hydroxide
Drug groups [BR:br08330]
Hormonal agent
DG01629 Adrenocorticotropic hormone (ACTH)
DG00492 Corticotropin
|
Other DBs |
|
LinkDB |
|